Mereo BioPharma Group
MREO
#7416
Rank
NZ$0.56 B
Marketcap
$3.56
Share price
-9.95%
Change (1 day)
-34.26%
Change (1 year)

Mereo BioPharma Group (MREO) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.12 Billion

According to Mereo BioPharma Group's latest financial reports the company has NZ$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mereo BioPharma Group - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$90.79 M-30.11%
2022-12-31NZ$0.12 B-48.34%
2021-12-31NZ$0.25 B316.25%
2020-12-31NZ$60.42 M44.78%
2019-12-31NZ$41.73 M-36.9%
2018-12-31NZ$66.13 M-51.06%
2017-12-31NZ$0.13 B14.76%
2016-12-31NZ$0.11 B199.71%
2015-12-31NZ$39.28 M